• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Enbee Trade & Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
512441
INE993I01029
1.1513695
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
6.5
69.11
EPS(TTM)
Face Value()
Div & Yield %
0.06
1
0
 

bal pharma ltd
Mazda secures Rs 25-cr order from Mumbai-based EPC consultant
Dec 02,2025
According to an exchange filing, the order is scheduled for completion over 11 months from the date of approval of technical drawings and documents. The company also clarified that neither its promoters nor the promoter group have any interest in the awarding authority, and the transaction does not qualify as a related-party deal under regulatory norms.

Mazda is engaged in the business of manufacturing engineering goods like vacuum products, evaporators, pollution control equipment and manufacturing of food products like food colour, various fruit jams & fruit mix powders, etc.

The company reported a standalone net profit of Rs 7.58 crore in Q2 FY26, down 15.6% from Rs 8.98 crore in Q2 FY25. However, revenue from operations fell 10.5% year-on-year (YoY) to Rs 50.84 crore in Q2 FY26.

The counter rose 0.47% to Rs 235.75 on the BSE.